Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

260010 Demethylasterriquinone B1 - CAS 78860-34-1 - Calbiochem

Demethylasterriquinone B1 - CAS 78860-34-1 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: L-783,281, DMAQ-B1, DAQ B1, 2-[2-(1,1-Dimethylallyl)-1H-indol-3-yl]-3,6-dihydroxy-5-[7-(3-methylbut-2-enyl)-1H-indol-3-yl][1,4]benzoquinone, 2,5-Dihydroxy-3-[7-(3-methyl-but-2-enyl)-1H-indol-3-yl]-6-[2-(1,1-dimethyl-allyl)-1H-indol-3-yl]-[1,4]benzoquinone

Primary Target: Insulin receptor (IR) tyrosine kinase activity
260010
  
Purchase on Sigma-Aldrich

Áttekintés

Replacement Information

Kulcsspecifikációk táblázata

CAS #Empirical Formula
78860-34-1C₃₂H₃₀N₂O₄
Description
Overview

This product has been discontinued.



A cell-permeable unsymmetrical bis-indolylquinone insulin mimic with anti-diabetic activity in animal models. Selectively stimulates insulin receptor (IR) tyrosine kinase activity (EC50 ~ 6 µM in CHO•IR cells), while showing little effect towards IGF-1R, EGFR, or PDGFR. Also acts as an agonist for the neurotrophin receptors TrkA, B, and C in both cortical neurons and dorsal root ganglion neurons (~ 20 µM). DMAQ-B1 and insulin show differential effects on cellular gene expression profiles and DMAQ-B1 is a more selective agonist than insulin for the IR-mediated activation of PI-3 kinase/Akt pathway.
Catalogue Number260010
Brand Family Calbiochem®
SynonymsL-783,281, DMAQ-B1, DAQ B1, 2-[2-(1,1-Dimethylallyl)-1H-indol-3-yl]-3,6-dihydroxy-5-[7-(3-methylbut-2-enyl)-1H-indol-3-yl][1,4]benzoquinone, 2,5-Dihydroxy-3-[7-(3-methyl-but-2-enyl)-1H-indol-3-yl]-6-[2-(1,1-dimethyl-allyl)-1H-indol-3-yl]-[1,4]benzoquinone
References
ReferencesWebster, N.J., et al. 2003. Chembiochem 4, 379.
Pirrung, M.C., et al. 2002. J. Org. Chem. 6, 23.
Westerlund, J., et al. 2002. Diabetes 51, S50.
Roper, M.G., et al. 2002. Diabetes 51, S43.
Air, E.L., et al. 2002. Nat. Med. 8, 179.
Wilkie, N., et al. 2001. J. Neurochem. 78, 1135.
Salituro, G.M., et al. 2001. Recent Prog. Horm. Res. 56, 107.
Liu, K., et al. 2000. J. Med. Chem. 43, 3487.
Zhang, B., et al. 1999. Science 284, 974.
Product Information
CAS number78860-34-1
ATP CompetitiveN
FormBluish black solid
Hill FormulaC₃₂H₃₀N₂O₄
Chemical formulaC₃₂H₃₀N₂O₄
ReversibleN
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Biological Information
Primary TargetInsulin receptor (IR) tyrosine kinase activity
Primary Target IC<sub>50</sub>EC50 ~ 6 µM stimulating insulin receptor (IR) tyrosine kinase activity in CHO•IR cells
Purity≥95% by HPLC
Physicochemical Information
Cell permeableY
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Shipped with Blue Ice or with Dry Ice
Toxicity Irritant
Storage -20°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Katalógusszám GTIN
260010 0

Documentation

Demethylasterriquinone B1 - CAS 78860-34-1 - Calbiochem MSDS

Title

Safety Data Sheet (SDS) 

Demethylasterriquinone B1 - CAS 78860-34-1 - Calbiochem Certificates of Analysis

TitleLot Number
260010

References

Hivatkozások áttekintése
Webster, N.J., et al. 2003. Chembiochem 4, 379.
Pirrung, M.C., et al. 2002. J. Org. Chem. 6, 23.
Westerlund, J., et al. 2002. Diabetes 51, S50.
Roper, M.G., et al. 2002. Diabetes 51, S43.
Air, E.L., et al. 2002. Nat. Med. 8, 179.
Wilkie, N., et al. 2001. J. Neurochem. 78, 1135.
Salituro, G.M., et al. 2001. Recent Prog. Horm. Res. 56, 107.
Liu, K., et al. 2000. J. Med. Chem. 43, 3487.
Zhang, B., et al. 1999. Science 284, 974.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision15-June-2008 RFH
SynonymsL-783,281, DMAQ-B1, DAQ B1, 2-[2-(1,1-Dimethylallyl)-1H-indol-3-yl]-3,6-dihydroxy-5-[7-(3-methylbut-2-enyl)-1H-indol-3-yl][1,4]benzoquinone, 2,5-Dihydroxy-3-[7-(3-methyl-but-2-enyl)-1H-indol-3-yl]-6-[2-(1,1-dimethyl-allyl)-1H-indol-3-yl]-[1,4]benzoquinone
DescriptionA cell-permeable unsymmetrical bis-indolylquinone insulin mimic with anti-diabetic activity in animal models. Selectively stimulates insulin receptor (IR) tyrosine kinase activity (EC50 ~6 µM in CHO•IR cells), while showing little effect towards IGF-1R, EGFR, or PDGFR. Also acts as an agonist for the neurotrophin receptors TrkA, B, and C in both cortical neurons and dorsal root ganglion neurons (~20 µM). DMAQ-B1 and insulin show differential effects on cellular gene expression profiles and DMAQ-B1 is a more selective agonist than insulin for the IR-mediated activation of PI-3 kinase/Akt pathway.
FormBluish black solid
Intert gas (Yes/No) Packaged under inert gas
CAS number78860-34-1
Chemical formulaC₃₂H₃₀N₂O₄
Structure formulaStructure formula
Purity≥95% by HPLC
SolubilityDMSO (50 mg/ml)
Storage Protect from light
-20°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity Irritant
ReferencesWebster, N.J., et al. 2003. Chembiochem 4, 379.
Pirrung, M.C., et al. 2002. J. Org. Chem. 6, 23.
Westerlund, J., et al. 2002. Diabetes 51, S50.
Roper, M.G., et al. 2002. Diabetes 51, S43.
Air, E.L., et al. 2002. Nat. Med. 8, 179.
Wilkie, N., et al. 2001. J. Neurochem. 78, 1135.
Salituro, G.M., et al. 2001. Recent Prog. Horm. Res. 56, 107.
Liu, K., et al. 2000. J. Med. Chem. 43, 3487.
Zhang, B., et al. 1999. Science 284, 974.